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probed its functional relevance in porphyria using a
chemical model of this disease. Mice were treated with
chemicals such as lead that inhibit specific enzymes of
the heme biosynthetic pathway (see Figure 1A) result-
ing in “priming,” a condition that mimics the partial loss
of function in heme biosynthesis seen in genetic por-
phyria. Chemical treatment was combined with fasting
to precipitate a “porphyria attack” in mice. In a gain-
of-function experiment, overexpression of PGC-1α by
virus-mediated transduction, in combination with fast-
ing and chemical treatment, led to a dramatic increase
in expression of ALAS-1. Plasma levels of the porphyrin
precursors ALA and PBG were dramatically increased
in these animals, to levels comparable to those seen
in genetic mouse models of porphyria (Lindberg et al.,
1996). Thus, ectopic expression of PGC-1α in conjunc-
tion with fasting and chemical treatment created a
“porphyria attack” in otherwise normal animals. In con-
trast, wild-type animals subjected to the same fasting
and chemical regimen but in the absence of ectopic
PGC-1α exhibited a moderate increase in ALAS-1
mRNA and in porphyrin precursors such as ALA. Re-
markably, this moderate increase in ALAS-1 and in
heme precursors was completely ablated in animals
with liver-specific deletion of PGC-1α, suggesting that
these animals are protected from the milder “porphyria-
like” symptoms induced by the combined fasting and
chemical treatment. Taken together, the gain- and loss-
of-function experiments strongly indicate that PGC-1α
is a key factor that mediates the expression of ALAS-1
during porphyria attacks.
Short of directly examining the effects of PGC-1α
loss in a genetic mouse model of porphyria, the study
by Handschin et al. nevertheless clearly indicates that
PGC-1α is the culprit behind the precipitation of por-
phyria attacks by fasting. Thus, fasting induces expres-
sion in the liver of PGC-1α, which then acts as a power-
ful coactivator for the transcription factors NRF-1 and
FOXO1, resulting in enhanced ALAS-1 expression and
an increased risk of a porphyria attack (see Figure 1B).
Glucose administration, together with the resulting sec-
ondary increase in insulin, ameliorates this risk through
two independent mechanisms: first, by directly antago-
nizing the induction of PGC-1α expression and second,
by reducing the association between PGC-1α and
FOXO1 (see Figure 1B).
Given that the power of the sweet treat for porphyria
lies in the ability of glucose to tame PGC-1α, one could
envisage alternative (less calorific) treatments that
could target PGC-1α in the liver directly by, for exam-
ple, modulating its expression, activity, or its interaction
with relevant transcription factors. Although the devel-
opment of such therapeutics lies in the future, the new
study by Handschin et al. represents a vivid example of
an initial endeavor in a seemingly unrelated research
area (adipocyte metabolism) that has yielded therapeu-
tic insights into a human disease (porphyria). No doubt,
future studies will use mouse genetic models of por-
phyria (Lindberg et al., 1996) to directly examine the
function of PGC-1α. It will also be intriguing to test
whether loss of PGC-1α would sufficiently dampen the
overall activity of the ALAS-1 promoter such that this loss
might offer protection from attacks induced by drugs
such as phenobarbital despite the fact that these drugs
activate ALAS-1 in a PGC-1α-independent manner.
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A New Map for Navigating
the Yeast Epigenome
The posttranslational modification of histones by
acetylation or methylation regulates chromatin struc-
ture and can determine how a DNA sequence is inter-
preted by, for example, the transcriptional machinery.
In this issue of Cell, Pokholok and colleagues (2005)
describe a new and reliable genome-wide microarray
study of histone modifications and gene expression
in yeast. Their epigenetic map can be used to guide
further research on the epigenome.
Epigenetic modifications of DNA or associated pro-
teins, such as histones, have traditionally been studied
on a gene-by-gene basis. However, the idea has re-
cently emerged that the distribution of modifications
could be mapped across the entire genome, providing
valuable insights into the generality or specificity of
regulatory mechanisms. Unlike the DNA sequence, this
representation of the physical genome is expected to
vary among cell types, throughout the cell cycle, or in
response to specific stimuli. Consequently, many epi-
genomes must exist, raising the question of how to
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490best map and interpret them all. Those who believe in
the notion of epigenomics hold, as an article of faith,
that this endeavor will reveal features that are both re-
producible and predictive. The work of Pokholok et al.
(2005) in this issue provides reassurance that such faith
is justified.
Pokholok and colleagues (2005) assess the distribu-
tion of modified histones in both genes and intergenic
regions and show that different modifications pre-
dominate at the beginning, middle, and end of genes.
Collectively, their results demonstrate a fascinating dif-
ference between histone acetylation and histone meth-
ylation across the yeast genome (see Figure 1). Their
work indicates that histones are acetylated in a coordi-
nated manner peaking at the beginning of genes,
whereas there are striking differences in the distribution
of methylated histones depending on the degree
(mono-, di-, or tri-) of methylation and the lysine that
is methylated.
The current method of choice for epigenetic map-
ping, and the one used here by Pokholok and col-
leagues (2005) is chromatin immunoprecipitation (ChIP)
followed by analysis of the precipitated DNA on micro-
arrays. This “ChIP-chip” procedure generates data on
a genomic scale. Although the approach of Pokholok
and coworkers is conventional, from a technical stand-
point, two things make their work stand out. First, the
study demonstrates unequivocally the importance of
attention to experimental detail and the use of appro-
priate controls. Second, the results are consistent, can
be interpreted readily, and provide guidelines for future
experimentation.
The authors set out to map the distribution of specific
histone modifications thought to be closely involved in
the regulation of gene expression, namely acetylation
of histones H3 and H4 at various lysines and methyla-
tion of H3 at lysines K4, K36, and K79. Their results
show that histone acetylation is consistently higher at
the beginning of genes (see Figure 1) and that levels of
acetylated H3K9, H3K14, and hyperacetylated H4 are
positively correlated both with one another and with
transcriptional activity. The results also indicate that
methylation of H3K4 correlates with both acetylation
and transcription. However, although the different acet-
ylated histones all behave in much the same way, there
are striking differences in the distribution of mono-,
di-, and trimethylated H3K4. Trimethylated H3K4 is en-
riched at the beginning of transcribed regions, whereas
dimethylated H3K4 is enriched in the middle of genes,
and the monomethylated form is most abundant toward
the end of genes (see Figure 1). The finding that the
degree of methylation matters is consistent with pre-
vious analyses in yeast and in higher eukaryotes
(Wysocka et al., 2005, and references therein). What is
remarkable is not so much that this distribution oc-
curs—it has been observed before with individual genes
(Ng et al., 2003)—but that it is so consistent across the
yeast genome.
Also, although trimethylated H3K36 and trimethy-
lated H3K79 are both enriched across coding regions
(see Figure 1), H3K36 becomes more heavily trimethy-
lated as transcriptional activity increases, but H3K79
does not (although there is a small decrease in trimeth-
ylated H3K79 in the least active gene set). This differs
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from findings in the fruit fly Drosophila, which reveal
hat dimethylated H3K79 correlates closely with tran-
cription (Schübeler et al., 2004). This probably reflects
lower overall abundance of H3K79 methylation and
he much smaller proportion of the genome that is tran-
cribed in higher eukaryotes.
Experiments using ChIP-chip offer enormous poten-
ial but are fraught with difficulties. Unfortunately, al-
ost every experiment will generate a “map” of some
ort, given the sensitivity of microarray detection meth-
ds and the wealth of data generated. In deciding what
o believe, it is important to ask whether experimental
nd analytical steps have been subjected successfully
o biological tests. Pokholok et al. (2005) provide two
uch tests. First, they show that their ChIP-chip pro-
edure locates the transcriptional regulator Gcn4 di-
ectly over those sites where genome sequence and
ene expression analysis predicts it should be. This
inding suggests a frequency of false positives of <1%
nd of false negatives of w25%. Second, their ChIP-
hip procedure reveals that nucleosome occupancy
that is, the density of nucleosomes) decreases at genes
ctivated in response to oxidative stress, whereas his-
one acetylation increases consistent with previous re-
ults (e.g., Reinke and Horz, 2003).
Overall, the results of Pokholok et al. (2005) comple-
ent and extend our current knowledge concerning the
ssociation between histone modifications and tran-
cription in yeast and higher eukaryotes. For example,
n both humans and Drosophila, there is a strong corre-
ation between acetylation of H3 and H4, methylation
f H3K4, and transcriptional activity (Bernstein et al.,
005, Schübeler et al., 2004). However, these findings
re in striking contrast to the conclusions of a recent
omprehensive ChIP-chip analysis by Kurdistani et al.
2004) of acetylated histone isoforms across the yeast
enome. Initial comparisons by these authors of en-
ichment for each acetylated lysine (conducted essen-
ially as in the Pokholok et al. study) revealed positive
orrelations, suggesting that genomic regions that are
nriched in one acetylated lysine also tend to be en-
iched in others. However, after subjecting the data to
ariance normalization, they found no general correla-
ion between acetylation levels at different lysines or
etween acetylation and transcription. Based on clus-
ering analysis of the variance normalized data, Kurdis-
ani et al. propose that complex combinations of acet-
lated histones define functionally related groups of
enes.
The analytical procedures used by these two groups
ay contribute to the discrepancy between their find-
ngs. Variance normalization takes the mean acetylation
evel for all lysines at a given sequence, subtracts it
rom each individual measurement, and divides by the
tandard deviation, thus shifting the focus from analyz-
ng the level of enrichment (the result of the ChIP exper-
ment) to analyzing the variability of acetylation be-
ween individual lysines, regardless of the actual level
f acetylation. Further analysis is required to determine
ow sensitive this approach is to experimental noise
nd whether it confounds comparisons between ly-
ines (van Leeuwen and van Steensel, 2005).
Also, Kurdistani and colleagues (2004) did not allow
or nucleosome occupancy or the selective nonspecific
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491Figure 1. Distribution of Histone Modifica-
tions across a Typical Yeast Gene
In their ChIP-chip assay, Pokholok et al.
(2005) immunoprecipitated formaldehyde-
crosslinked yeast chromatin with antibodies
to acetylated histones H3 and H4, and to H3
histone mono-, di-, or trimethylated at lysine
36 (H3K36), lysine 79 (H3K79), and lysine 4
(H3K4). The authors amplified immunopreci-
pitated and input DNA by ligation-mediated
PCR, labeled them with different fluorescent
dyes, and mixed and hybridized them to a
single DNA microarray. The ratio of both flu-
orescent dyes on each spot provides a mea-
sure of the relative enrichment of the histone
modification under investigation. Collectively,
this provides information with which to con-
struct a genome-wide map of the consensus
distribution of histone modifications in yeast.
Each of the distributions shown represents a
composite profile derived from several hun-
dred genes.precipitation of coding DNA (ORFs) in their ChIP experi-
ments, possibly obscuring any correlation between
acetylation and transcription. It has recently been
shown that nucleosome density is not homogeneous
across the yeast genome, but is generally lower at in-
tergenic regions, which in the compact yeast genome
are mostly promoters (Lee et al., 2004). Pokholok and
colleagues (2005) confirm this by showing that antibod-
ies to unmodified H3 and H4 precipitated less chroma-
tin from intergenic regions than from coding regions.
Moreover, they also find that adding an irrelevant anti-
body, or even no antibody at all, results in detectable
enrichment of coding as opposed to intergenic DNA,
suggesting an intrinsic bias toward precipitation of re-
gions with high nucleosomal occupancy. Importantly,
correcting for nucleosomal density reveals enhanced
histone acetylation at active promoters that otherwise
would have escaped detection.
The conflicting conclusions drawn by Pokholok et al.
(2005) and Kurdistani et al. (2004) go to the heart of
how we think about histone acetylation. Is it a lysine-
specific process operating in diverse ways, or is it a
general mechanism based on charge that opens up
chromatin to facilitate transcription? Beyond the two
papers themselves, other evidence suggests that both
mechanisms are likely to be important. For example,
Dion et al. (2005) have recently shown that substituting
yeast H4 lysines 5, 8, or 12 with arginine (individually or
collectively, thus blocking acetylation) had similar ef-
fects, whereas substitution of H4 lysine 16 produced a
distinct transcriptional response. Also, so far, only Kur-
distani et al. have attempted the daunting task of ana-
lyzing the (nearly) complete set of lysines capable of
being acetylated. Certainly, further experimentation is
urgently needed, but it appears most likely that H3/H4
acetylation exerts a general, charge-based effect on
chromatin structure that is moderated by local changes,
while some acetylated lysines can exert specific ef-
fects.
It is now common practice to describe the results of
ChIP-chip experiments as epigenetic maps. However,
a complete epigenetic map will not only define thechromosomal positions of histone modifications but
also those of nonhistone proteins, DNA, and noncoding
RNAs. In addition, the information provided by this ap-
proach is surely more than just a map. That simple de-
scription may even be misleading. After all, a sailor
uses a map to locate sandbanks or marker buoys, but
he also looks over the side occasionally to judge the
height of waves and the direction of the wind—the con-
stantly changing variables not found on any map. The
chromatin maps to date have largely been concerned
with defining histone modifications associated with on-
going transcription. Yet a critical question remains: are
these modifications simply a consequence of transcrip-
tion, or are they stable features independent of the pro-
cess itself that define regions of the genome where
transcription may occur under appropriate conditions?
When this issue is resolved for each modification, then
ChIP-chip data may provide both a map and a tran-
scriptional weather forecast.
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